EXPLOITING RHOA MUTATIONS IN DIFFUSE GASTRIC ADENOCARCINOMA AND TARGETING INTERTWINED RHOA AND YAP1 PATHWAYS FOR THERAPEUTIC ADVANTAGE
$640,000FY2016Department of the ArmyDOD
The Univeristy Of Texas M.D. Anderson Cancer Center
The Univeristy Of Texas M.D. Anderson Cancer Center